Crossmark

Construction and validation of a nomogram prediction model for the risk of new-onset atrial fibrillation following percutaneous coronary intervention in acute myocardial infarction patients

Crossref DOI link: https://doi.org/10.1186/s12872-024-04326-8

Published Online: 2024-11-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Li-Xiang

Cao, Jiao-Yu

Zhou, Xiao-Juan
License Information

Text and Data Mining valid from 2024-11-13

Version of Record valid from 2024-11-13
More Information

Article History

Received: 28 May 2024

Accepted: 7 November 2024

First Online: 13 November 2024

Declarations

:

: The Medical Ethics Committee at the First Affiliated Hospital of the University of Science and Technology of China approved the study protocol (Approval number: 2024-RE-386), ensuring compliance with the principles outlined in the <i>Declaration of Helsinki</i>. Additionally, the study has been registered in the Chinese Clinical Trial Registry under the registration number ChiCTR2400091026. Given the retrospective design of the study, informed consent from participants was waived.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below